These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1504290)

  • 1. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes.
    Schmage N; Bergener M
    Int Psychogeriatr; 1992; 4 Suppl 1():89-99. PubMed ID: 1504290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine in the treatment of old age dementias.
    Ban TA; Morey L; Aguglia E; Azzarelli O; Balsano F; Marigliano V; Caglieris N; Sterlicchio M; Capurso A; Tomasi NA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):525-51. PubMed ID: 2236581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca2+ homeostasis in dementia.
    Fischhof PK
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):549-55. PubMed ID: 7794292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional rating scales and psychometric assessment in Alzheimer's disease: applications in pharmacological trials.
    Oswald WD; Gunzelmann T
    Int Psychogeriatr; 1992; 4 Suppl 1():79-88. PubMed ID: 1504289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
    Parnetti L; Mecocci P; Petrini A; Longo A; Buccolieri A; Senin U
    Neuropsychobiology; 1989; 22(2):97-100. PubMed ID: 2518332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal-detection analysis of nonverbal recognition memory in dementia.
    Taylor R; Gilleard CJ
    Percept Mot Skills; 1990 Dec; 71(3 Pt 2):1255-8. PubMed ID: 2087378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxiracetam in dementia: a double-blind, placebo-controlled study.
    Bottini G; Vallar G; Cappa S; Monza GC; Scarpini E; Baron P; Cheldi A; Scarlato G
    Acta Neurol Scand; 1992 Sep; 86(3):237-41. PubMed ID: 1414239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drawing designs from memory in dementia.
    Taylor R
    Percept Mot Skills; 1994 Oct; 79(2):801-2. PubMed ID: 7870506
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium channel blocker nimodipine for primary degenerative dementia.
    Jarvik LF
    Biol Psychiatry; 1991 Dec; 30(11):1171-2. PubMed ID: 1777531
    [No Abstract]   [Full Text] [Related]  

  • 13. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia].
    Bukatina EE; Grigor'eva IV; Smirnov OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):38-42. PubMed ID: 8009931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous figure recognition in dementia and unilateral cerebral damage.
    Lang CJ
    Neuropsychologia; 1989; 27(5):619-28. PubMed ID: 2472574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responders and non-responders to bifemelane hydrochloride in Alzheimer-type and multi-infarct dementia.
    Shigeta M; Nishikawa Y; Shimizu M; Usui M; Hyoki K; Kawamuro Y
    Int Clin Psychopharmacol; 1993; 8(2):109-14. PubMed ID: 8345159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of performance on the Fuld Object Memory Evaluation in elderly inpatients with depression or dementia.
    La Rue A
    J Clin Exp Neuropsychol; 1989 Aug; 11(4):409-22. PubMed ID: 2760177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.
    Wadworth AN; McTavish D
    Drugs Aging; 1992; 2(4):262-86. PubMed ID: 1504442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ateroid in the treatment of dementia: results of a clinical trial.
    Conti L; Placidi GF; Cassano GB
    Mod Probl Pharmacopsychiatry; 1989; 23():76-84. PubMed ID: 2469952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.